Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
about
Cancer-associated thrombotic microangiopathyMembranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesotheliomaGemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate.Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Nephrotoxicity of recent anti-cancer agents.Drug-induced nephropathy: an update.The kidney in oncology.Gemcitabine induced hemolytic uremic syndrome.Use of eculizumab in refractory gemcitabine-induced thrombotic microangiopathy.The use of eculizumab in gemcitabine induced thrombotic microangiopathy.ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.Gemcitabine-induced haemolytic uremic syndrome, although infrequent, can it be prevented: A case report and review of literature
P2860
Q26738984-807D7ACC-A836-4DFD-AF21-451810539BD2Q28374544-C9CC73CB-D90F-44DD-A77A-80407FDC39B7Q33410709-7A648A1E-1219-401E-A650-B6CF6F3BBCFEQ33413284-E6E898F4-BFC1-41B2-A45D-E7FE824C6D5EQ33419794-F31A7844-BB95-4EBD-807A-8267B02407E6Q33434397-8BC25BA2-4B75-4FEE-81B6-92ADD6CC45E4Q34122035-CB135107-2D43-4997-8618-3B2CF5E42C15Q35310741-A695978D-69A2-4A8C-A680-D2269927A0F3Q36191026-547C0C69-C6E4-4C10-8924-FDBFD38704D4Q36900332-013A2996-6B7E-4D51-BDEA-727DBA87ACDAQ39569221-635D7083-FFFE-4E5B-B5F0-8605184F9544Q44441605-1BF24894-E5DE-483B-A897-9C06C56D2221Q47554154-3C25A07C-E6B9-4235-9AEF-11253B5520AFQ47630342-D1F9F765-A77F-4FD6-B1DE-A548E224DCF0Q58551524-205378B7-5488-4066-AF94-9BC3EEC19E5A
P2860
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@ast
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@en
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@nl
type
label
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@ast
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@en
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@nl
prefLabel
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@ast
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@en
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@nl
P2093
P1476
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
@en
P2093
C D Flombaum
E S Casper
F Benedetti
J A Mouradian
R A Erlandson
P304
P356
10.1016/S0272-6386(99)70194-0
P577
1999-03-01T00:00:00Z